CELC earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -23.17. Updated 2026-07-23.
Celcuity (CELC) Research Hub
Celcuity (CELC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 65.8 USD (+0.84%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -23.17, market cap 4.40B. This hub links to the full technical, earnings and options research available for CELC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 65.8 USD (+0.84%) |
| 52-week range | 53.54 USD – 117.21 USD |
| Trend regime | Range |
| 14-day RSI | 40.8 (Bearish) |
| Trailing P/E | -23.17 |
| Market cap | 4.40B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for CELC
Covered Call on CELC: how it works, illustrative setup around the real 65.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CELC: how it works, illustrative setup around the real 65.8 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CELC: how it works, illustrative setup around the real 65.8 USD price, max profit/loss, breakeven and when to use it. Educational.
CELC technical analysis: range, last 65.8 USD, RSI 40.8, 52w range 53.54 USD–117.21 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CELC in?
Celcuity (CELC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is CELC in an uptrend or downtrend?
As of 2026-10-26, CELC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CELC's trailing P/E ratio?
CELC's trailing P/E is -23.17, with a market cap of 4.40B. See the earnings research page for full valuation detail.
When does CELC next report earnings?
CELC is next scheduled to report earnings on 2026-08-13.